International Journal of Research in Business and Social Science

International Journal of Research in Business and Social Science

Advertising to the End Consumers by Pharmaceutical Companies: Blessing or Curse?

Yazarlar: Scott Goldberg

Cilt 2 , Sayı 4 , 2013 , Sayfalar -

Konular:

Anahtar Kelimeler:Advertising Pharmaceutical Ethical Issues Corporate Responsibility Marketing

Özet: The last several years have seen an increase in the number of direct to consumer advertisements by pharmaceutical companies. Direct to Consumer advertisements (DTC) means targeting the end consumer through advertisements on television, radio, in newspapers, magazines, and the Internet. The qualitative study presents data and supports the need for a future quantitative study to ask physicians and consumers their opinions on whether pharmaceutical companies should be allowed to advertise directly to the end consumer. This article reviews the literature on this controversial topic, supporting the need to explore the reserach questions in greater detail. A review of the literature suggests there is financial motivation on the part of the pharmaceutical companies to increase their sales by advertsing directly to the end consumer as opposed to performing an educational service to the consumer.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2013, title={Advertising to the End Consumers by Pharmaceutical Companies: Blessing or Curse?}, volume={2}, number={0}, publisher={International Journal of Research in Business and Social Science}, author={Scott Goldberg}, year={2013} }
APA
KOPYALA
Scott Goldberg. (2013). Advertising to the End Consumers by Pharmaceutical Companies: Blessing or Curse? (Vol. 2). Vol. 2. International Journal of Research in Business and Social Science.
MLA
KOPYALA
Scott Goldberg. Advertising to the End Consumers by Pharmaceutical Companies: Blessing or Curse? no. 0, International Journal of Research in Business and Social Science, 2013.